Persistence of interleukin-17 and interleukin-23 inhibitors in patients with plaque psoriasis: a real-world study in Taiwan

Objectives IL-17 inhibitors (IL-17i) and IL-23 inhibitors (IL-23i) are advanced treatments for moderate-to-severe plaque psoriasis. This study aimed to assess the persistence of IL-17i and IL-23i in patients with plaque psoriasis in Taiwan, where a unique healthcare reimbursement policy makes biolog...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Yu-Huei Huang, Youran Xu, Shu-Chen Chang, Yu-Jr Lin, Chia-Ling Chang, Grace Hui-Min Wu, Yongjing Zhang, Bryan Wahking, Hong Qiu, Chee Jen Chang
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Taylor & Francis Group 2026-12-01
Serie:	Journal of Dermatological Treatment
Soggetti:	Plaque psoriasis persistence interleukin-17 inhibitor interleukin-23 inhibitor real-world evidence discontinuation
Accesso online:	https://www.tandfonline.com/doi/10.1080/09546634.2025.2604952
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!